Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | METAP1 | P53582 | 2/20 | 0.48 |
| ▸ | CCR1 | P32246 | 2/20 | 0.48 |
| ▸ | CCR5 | P51681 | 2/20 | 0.48 |
| ▸ | CCR8 | P51685 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5142866 | 0.85 | CYP2A6 (0.48) | CYP2A6KDM4ELMNAMETAP1CCR1 | |
| SCHEMBL39129 | 0.79 | NPC1 (0.59) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL30229669 | 0.79 | NPC1 (0.59) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL30427456 | 0.79 | NPC1 (0.59) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL12854083 | 0.78 | KDM4E (0.50) | CYP2A6KDM4ELMNAMETAP1CCR1 | |
| SCHEMBL13798940 | 0.78 | PRKCI (0.46) | CYP2A6KDM4ELMNAMETAP1CCR1 | |
| SCHEMBL3714209 | 0.78 | NPC1 (0.57) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL23598962 | 0.77 | CYP2A6 (0.48) | CYP2A6KDM4ELMNAMETAP1CCR1 | |
| SCHEMBL17180121 | 0.77 | CYP2A6 (0.48) | CYP2A6KDM4ELMNAMETAP1CCR1 | |
| SCHEMBL16897143 | 0.77 | CYP2A6 (0.48) | CYP2A6KDM4ELMNAMETAP1CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825734-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| US-11818932-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| EP-4225006-A2 | ORGANIC LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2023-08-09 | — | — | EP | disclosed |
| US-11696496-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11678498-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| EP-3246963-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-31 | — | — | EP | disclosed |
| US-11653563-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-16 | — | — | US | disclosed |
| US-11617290-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-03-28 | — | — | US | disclosed |
| US-11329230-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-26 | — | — | US | disclosed |
| US-20170069847-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2017-03-09 | — | — | US | disclosed |
| US-20170069847-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2017-03-09 | — | — | US | disclosed |
| US-20170054085-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20170054085-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20160322579-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-11-03 | — | — | US | disclosed |
| US-20160293848-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160293845-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160285011-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-09-29 | — | — | US | disclosed |
| US-20160272621-A1 | GSK-3 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-09-22 | — | — | US | disclosed |
| US-8101774-B2 | Ester derivatives and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2012-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11329230-B2 | Organic light-emitting device | EML4, SUN2, TRPA1 | CYP2A6 1675/4885KDM4E 2540/4885LMNA 2238/4885 |
| US-11825734-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP | CYP2A6 1611/4885KDM4E 3905/4885LMNA 3477/4885 |
| US-20160293848-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | CYP2A6 2249/4885KDM4E 3752/4885LMNA 1208/4885 |
| US-20160285011-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | CCNA1, CCNT1, CCNE2 | CYP2A6 1507/4885KDM4E 4266/4885LMNA 642/4885 |
| US-20170069847-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | CYP2A6 2041/4885KDM4E 3395/4885LMNA 1574/4885 |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | OCIAD1, L3MBTL1, OCIAD2 | CYP2A6 2875/4885KDM4E 3548/4885LMNA 427/4885 |
| US-20160272621-A1 | GSK-3 INHIBITORS | GSK3B, GSK3A, GSKIP | CYP2A6 2029/4885KDM4E 2680/4885LMNA 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.